262 related articles for article (PubMed ID: 34694318)
1. Assessment of Nonfatal Myocardial Infarction as a Surrogate for All-Cause and Cardiovascular Mortality in Treatment or Prevention of Coronary Artery Disease: A Meta-analysis of Randomized Clinical Trials.
O'Fee K; Deych E; Ciani O; Brown DL
JAMA Intern Med; 2021 Dec; 181(12):1575-1587. PubMed ID: 34694318
[TBL] [Abstract][Full Text] [Related]
2. Antibiotics for secondary prevention of coronary heart disease.
Sethi NJ; Safi S; Korang SK; Hróbjartsson A; Skoog M; Gluud C; Jakobsen JC
Cochrane Database Syst Rev; 2021 Feb; 2(2):CD003610. PubMed ID: 33704780
[TBL] [Abstract][Full Text] [Related]
3. Assessment of Repeat Revascularization in Percutaneous Coronary Intervention Randomized Controlled Trials as a Surrogate for Mortality: A Meta-Regression Analysis.
Khan SU; Lone AN; Akbar UA; Arshad HB; Arshad A; Arora S; Kaluski E; Aoun J; Goel SS; Shah AR; Kleiman NS
Curr Probl Cardiol; 2023 Apr; 48(4):101555. PubMed ID: 36529233
[TBL] [Abstract][Full Text] [Related]
4. Omega-6 fats for the primary and secondary prevention of cardiovascular disease.
Hooper L; Al-Khudairy L; Abdelhamid AS; Rees K; Brainard JS; Brown TJ; Ajabnoor SM; O'Brien AT; Winstanley LE; Donaldson DH; Song F; Deane KH
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011094. PubMed ID: 30488422
[TBL] [Abstract][Full Text] [Related]
5. Coronary artery calcification outperforms thoracic aortic calcification for the prediction of myocardial infarction and all-cause mortality: the Heinz Nixdorf Recall Study.
Kälsch H; Lehmann N; Berg MH; Mahabadi AA; Mergen P; Möhlenkamp S; Bauer M; Kara K; Dragano N; Hoffmann B; Moebus S; Schmermund A; Stang A; Jöckel KH; Erbel R
Eur J Prev Cardiol; 2014 Sep; 21(9):1163-70. PubMed ID: 23467675
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of multiple primary prevention trials of cardiovascular events using aspirin.
Bartolucci AA; Tendera M; Howard G
Am J Cardiol; 2011 Jun; 107(12):1796-801. PubMed ID: 21481826
[TBL] [Abstract][Full Text] [Related]
7. Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials.
Casula M; Olmastroni E; Gazzotti M; Galimberti F; Zambon A; Catapano AL
Pharmacol Res; 2020 Oct; 160():105060. PubMed ID: 32634581
[TBL] [Abstract][Full Text] [Related]
8. Death and Myocardial Infarction Following Initial Revascularization Versus Optimal Medical Therapy in Chronic Coronary Syndromes With Myocardial Ischemia: A Systematic Review and Meta-Analysis of Contemporary Randomized Controlled Trials.
Soares A; Boden WE; Hueb W; Brooks MM; Vlachos HEA; O'Fee K; Hardi A; Brown DL
J Am Heart Assoc; 2021 Jan; 10(2):e019114. PubMed ID: 33442990
[TBL] [Abstract][Full Text] [Related]
9. Effects of Percutaneous Coronary Intervention on Death and Myocardial Infarction Stratified by Stable and Unstable Coronary Artery Disease: A Meta-Analysis of Randomized Controlled Trials.
Chacko L; P Howard J; Rajkumar C; Nowbar AN; Kane C; Mahdi D; Foley M; Shun-Shin M; Cole G; Sen S; Al-Lamee R; Francis DP; Ahmad Y
Circ Cardiovasc Qual Outcomes; 2020 Feb; 13(2):e006363. PubMed ID: 32063040
[TBL] [Abstract][Full Text] [Related]
10. Initial coronary stent implantation with medical therapy vs medical therapy alone for stable coronary artery disease: meta-analysis of randomized controlled trials.
Stergiopoulos K; Brown DL
Arch Intern Med; 2012 Feb; 172(4):312-9. PubMed ID: 22371919
[TBL] [Abstract][Full Text] [Related]
11. Bayesian Interpretation of the EXCEL Trial and Other Randomized Clinical Trials of Left Main Coronary Artery Revascularization.
Brophy JM
JAMA Intern Med; 2020 Jul; 180(7):986-992. PubMed ID: 32478838
[TBL] [Abstract][Full Text] [Related]
12. Impact of candesartan on nonfatal myocardial infarction and cardiovascular death in patients with heart failure.
Demers C; McMurray JJ; Swedberg K; Pfeffer MA; Granger CB; Olofsson B; McKelvie RS; Ostergren J; Michelson EL; Johansson PA; Wang D; Yusuf S;
JAMA; 2005 Oct; 294(14):1794-8. PubMed ID: 16219883
[TBL] [Abstract][Full Text] [Related]
13. Meta-Analysis Comparing the Risk of Myocardial Infarction Following Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention in Patients With Multivessel or Left Main Coronary Artery Disease.
Lee PH; Park H; Lee JS; Lee SW; Lee CW
Am J Cardiol; 2019 Sep; 124(6):842-850. PubMed ID: 31311660
[TBL] [Abstract][Full Text] [Related]
14. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL study, a multicenter, randomized controlled trial from the Italian Cardiac Rehabilitation Network.
Giannuzzi P; Temporelli PL; Marchioli R; Maggioni AP; Balestroni G; Ceci V; Chieffo C; Gattone M; Griffo R; Schweiger C; Tavazzi L; Urbinati S; Valagussa F; Vanuzzo D;
Arch Intern Med; 2008 Nov; 168(20):2194-204. PubMed ID: 19001195
[TBL] [Abstract][Full Text] [Related]
15. Aspirin for the prevention of cardiovascular events in patients with peripheral artery disease: a meta-analysis of randomized trials.
Berger JS; Krantz MJ; Kittelson JM; Hiatt WR
JAMA; 2009 May; 301(18):1909-19. PubMed ID: 19436018
[TBL] [Abstract][Full Text] [Related]
16. Relationship of body mass index with total mortality, cardiovascular mortality, and myocardial infarction after coronary revascularization: evidence from a meta-analysis.
Sharma A; Vallakati A; Einstein AJ; Lavie CJ; Arbab-Zadeh A; Lopez-Jimenez F; Mukherjee D; Lichstein E
Mayo Clin Proc; 2014 Aug; 89(8):1080-100. PubMed ID: 25039038
[TBL] [Abstract][Full Text] [Related]
17. Routine invasive strategies versus selective invasive strategies for unstable angina and non-ST elevation myocardial infarction in the stent era.
Fanning JP; Nyong J; Scott IA; Aroney CN; Walters DL
Cochrane Database Syst Rev; 2016 May; 2016(5):CD004815. PubMed ID: 27226069
[TBL] [Abstract][Full Text] [Related]
18. Comparison of mid- to long-term clinical outcomes between anatomical testing and usual care in patients with suspected coronary artery disease: A meta-analysis of randomized trials.
Hwang IC; Choi SJ; Choi JE; Ko EB; Suh JK; Choi I; Kang HJ; Kim YJ; Kim JY
Clin Cardiol; 2017 Nov; 40(11):1129-1138. PubMed ID: 28914973
[TBL] [Abstract][Full Text] [Related]
19. Reduction of C-reactive protein is not associated with reduced cardiovascular risk and mortality in patients treated with statins. A meta-analysis of 22 randomized trials.
Savarese G; Rosano GM; Parente A; D'Amore C; Reiner MF; Camici GG; Trimarco B; Perrone-Filardi P
Int J Cardiol; 2014 Nov; 177(1):152-60. PubMed ID: 25499365
[TBL] [Abstract][Full Text] [Related]
20. Associations of Serum Nonesterified Fatty Acids With Coronary Heart Disease Mortality and Nonfatal Myocardial Infarction: The CHS (Cardiovascular Health Study) Cohort.
Huang NK; Bůžková P; Matthan NR; Djoussé L; Hirsch CH; Kizer JR; Longstreth WT; Mukamal KJ; Lichtenstein AH
J Am Heart Assoc; 2021 Mar; 10(6):e019135. PubMed ID: 33682438
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
